M&A news

USV PRIVATE LIMITED Acquires USV PRIVATE

USV PRIVATE LIMITED acquired by USV PRIVATE LIMITED

Acquisition$1,583Hospitals and Health CareIN

Get the full USV PRIVATE LIMITED company profile

Access contacts, investors, buying signals & more

Open in Dashboard
USV PRIVATE LIMITED logo
Acquired

USV PRIVATE LIMITED

IndiaHospitals and Health Care

Deal value

$1,583

February 13, 2026

USV PRIVATE LIMITED logo
Acquirer

USV PRIVATE LIMITED

Hospitals and Health Care

USV PRIVATE LIMITED has acquired USV PRIVATE LIMITED for $2,000. This corporate acquisition sees the established Indian healthcare company formally consolidate its extensive operations.

USV is a 62-year-old Indian healthcare company with robust pharmaceutical manufacturing, research, and marketing capabilities spanning both Pharma and Consumer businesses. Originating as a Revlon subsidiary, it now operates independently in domestic and international markets. The company holds leadership positions in therapeutic segments like Cardio and Diabetology in India, and maintains a significant presence in Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology, and CNS. Its international business exports a portfolio of small molecule APIs and finished dosages to over 65 countries.

The company operates seven manufacturing plants across India, a corporate office, and a Research & Development Center in Mumbai, supported by over 6,800 employees. These facilities are accredited by global regulators including USFDA, EMA, and MHRA, ensuring cGMP compliance. USV is ranked #1 by Rx and Value in the Oral Anti-Diabetic market and #1 by Rx and #4 by Value in the Cardiovascular diseases segment. It invests 3% of its revenue in R&D and holds 12 patents. USV’s Consumer Business includes Sebamed, a leading Baby and Personal care brand, ranking #3 in Indian Baby care, alongside other segments like Beauty, Food, and nutrition.

This acquisition, where USV PRIVATE LIMITED has bought USV PRIVATE LIMITED, represents a strategic internal consolidation aimed at reinforcing the company's comprehensive operational framework. The move is expected to streamline internal processes, optimize resource allocation across its diverse pharmaceutical and consumer health segments, and further solidify its market leadership. Synergies are anticipated through enhanced integration of its robust manufacturing, research, and marketing capabilities, ensuring a unified approach to its domestic and international markets, all while upholding its Credo values of excellence and customer orientation.

The combined entity, operating as USV PRIVATE LIMITED, is poised to continue its mission as a reliable health partner, leveraging its established infrastructure, therapy leadership, and market presence to drive future growth and innovation across its integrated businesses.

No buying signals identified yet.

Unlock GTM signals

Discover USV PRIVATE LIMITED's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at USV PRIVATE LIMITED.

Unlock decision-makers